Tolvaptan News
Tolvaptan currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Tolvaptan with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (SIADH).
- Evidence level: L1
- Predicted indications (20):
- polycystic kidney disease 3 with or without polycystic liver disease (100.0%)
- renal-hepatic-pancreatic dysplasia (100.0%)
- karyomegalic interstitial nephritis (100.0%)
- thoracic malformation (100.0%)
- polycystic kidney disease (100.0%)
- Joubert syndrome with renal defect (100.0%)
- adult familial nephronophthisis-spastic quadriparesia syndrome (100.0%)
- Ambras type hypertrichosis universalis congenita (100.0%)
- hypertrichosis (disease) (100.0%)
- malformation syndrome with odontal and/or periodontal component (100.0%)
- syndrome with a Dandy-Walker malformation as major feature (100.0%)
- isolated genetic hair shaft abnormality (100.0%)
- nephrogenic syndrome of inappropriate antidiuresis (99.9%)
- homozygous familial hypercholesterolemia (99.9%)
- Joubert syndrome with oculorenal defect (99.8%)
- Meckel syndrome, (99.8%)
- syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy (99.8%)
- hypoalphalipoproteinemia (99.8%)
- autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis (99.7%)
- congenital pulmonary lymphangiectasia (99.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.